Clinical Trial Update: A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ASP0456 in constipation-predominant irritable bowel syndrome (IBS-C) has completed. The update reports the study status but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• ASP0456

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Constipation-predominant Irritable Bowel Syndrome (IBS-C) | Phase 2 | Status: COMPLETED